1. Home
  2. TARA vs NSLR Comparison

TARA vs NSLR Comparison

Compare TARA & NSLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

SELL

Current Price

$2.30

Market Cap

159.6M

Sector

Health Care

ML Signal

SELL

Logo Neostellar Capital Corp. Common Stock

NSLR

Neostellar Capital Corp. Common Stock

SELL

Current Price

$5.52

Market Cap

180.3M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
TARA
NSLR
Founded
N/A
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
159.6M
180.3M
IPO Year
2014
2011

Fundamental Metrics

Financial Performance
Metric
TARA
NSLR
Price
$2.30
$5.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
5
Target Price
★ $25.33
$14.15
AVG Volume (30 Days)
★ 852.9K
285.6K
Earning Date
11-06-2026
11-03-2026
Dividend Yield
N/A
★ 4.63%
EPS Growth
★ 38.25
N/A
EPS
N/A
★ 3.89
Revenue
★ $2,948,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$14.90
P/E Ratio
★ N/A
$1.39
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$5.35
52 Week High
$7.82
$12.19

Technical Indicators

Market Signals
Indicator
TARA
NSLR
Relative Strength Index (RSI) 42.02 34.75
Support Level $2.19 N/A
Resistance Level $2.73 $6.38
Average True Range (ATR) 0.21 0.39
MACD 0.03 0.05
Stochastic Oscillator 34.43 19.74

Price Performance

Historical Comparison
TARA
NSLR

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

About NSLR Neostellar Capital Corp. Common Stock

Neostellar Capital Corp is an investment company focused on private, venture-backed businesses. It invests in companies that are not yet listed on a public stock exchange. It helps investors to gain exposure to a portfolio of VC-backed companies through a publicly traded stock.

Share on Social Networks: